Genomic factors that shape craniofacial outcome and neural crest vulnerability in FASD by Susan M. Smith et al.
REVIEW ARTICLE
published: 07 August 2014
doi: 10.3389/fgene.2014.00224
Genomic factors that shape craniofacial outcome and
neural crest vulnerability in FASD
Susan M. Smith1*, Ana Garic1, Mark E. Berres 2 and George R. Flentke1
1 Department of Nutritional Sciences, University ofWisconsin–Madison, Madison,WI, USA
2 Department of Animal Sciences, University ofWisconsin–Madison, Madison,WI, USA
Edited by:
Stephen Mason, Indiana University
School of Medicine, USA
Reviewed by:
Amancio Carnero, Instituto de
Biomedicina de Sevilla, Spain
Shaoyu Chen, University of Illinois,
USA
Johann Eberhart, The University of
Texas at Austin, USA
*Correspondence:
Susan M. Smith, Department of
Nutritional Sciences, University of
Wisconsin–Madison, 1415 Linden Dr.
Madison,WI 53706, USA
e-mail: suesmith@nutrisci.wisc.edu
Prenatal alcohol exposure (PAE) causes distinctive facial characteristics in some preg-
nancies and not others; genetic factors may contribute to this differential vulnerability.
Ethanol disrupts multiple events of neural crest development, including induction, survival,
migration, and differentiation. Animal models and genomic approaches have substantially
advanced our understanding of the mechanisms underlying these facial changes. PAE
during gastrulation produces craniofacial changes corresponding with human fetal alcohol
syndrome. These result because PAE reduces prechordal plate extension and suppresses
sonic hedgehog, leading to holoprosencephaly andmalpositioned facial primordia. Haploin-
sufﬁciency in sonic hedgehog signaling increases vulnerability to facial deﬁcits and may
inﬂuence some PAE pregnancies. In contrast, PAE during early neurogenesis produces
facial hypoplasia, preceded by neural crest reductions due to signiﬁcant apoptosis. Factors
mediating this apoptosis include intracellular calciummobilization, elevated reactive oxygen
species, and loss of trophic support from β-catenin/calcium, sonic hedgehog, and mTOR
signaling. Genome-wide SNP analysis links PDGFRA with facial outcomes in human PAE.
Multiple genomic-level comparisons of ethanol-sensitive and – resistant early embryos,
in both mouse and chick, independently identify common candidate genes that may
potentiallymodify craniofacial vulnerability, including ribosomal proteins, proteosome, RNA
splicing, and focal adhesion. In summary, research using animal models with genome-
level differences in ethanol vulnerability, as well as targeted loss-and gain-of-function
mutants, has clariﬁed the mechanisms mediating craniofacial change in PAE. The ﬁndings
additionally suggest that craniofacial deﬁcits may represent a gene–ethanol interaction for
some affected individuals. Genetic-level changes may prime individuals toward greater
sensitivity or resistance to ethanol’s neurotoxicity.
Keywords: fetal alcohol spectrum disorders, neural crest, sonic hedgehog, apoptosis, β-catenin, CaMKII, ribosome
biogenesis
INTRODUCTION
It is indisputable that genetic factors modulate individual risk for
alcoholism (see Edenberg and Foroud, 2013, for a recent review).
For example, allelisms in alcohol and aldehyde dehydrogenases
control blood alcohol levels and alcohol clearance rates. Allelisms
in neurotransmitter receptors and their downstream effectors
shape neuronal responses to alcohol reward, tolerance, and with-
drawal. However, our understanding of how genetic factors might
shape individual risk for fetal alcohol spectrum disorders (FASD)
is less well deﬁned. It is without question that prenatal alcohol
exposure (PAE) is teratogenic; indeed, it is the most common
teratogen exposure in western societies. However, there is appre-
ciable variability in the severity of individual responses to PAE,
even after controlling for the pattern, timing, and dose of alcohol
intake. Some of this variance is due to environmental factors that
include maternal nutrition and socioeconomic status. Evidence
has been accumulating that genetic factors can also shape individ-
ual risk for FASD (Warren and Li, 2005). Concordance for FASD
risk is greater in monozygotic than in dizygotic twins (Streissguth
andDehaene, 1993). The potential existence of geneticmodiﬁers is
strongly endorsed by animal models of FASD. Much of this animal
work emphasizesmorphological rather than behavioral outcomes.
When ethanol exposure is held constant, genetic factors modulate
the risk for cardiac, craniofacial, skeletal, and central nervous sys-
tem defects in the developing offspring, and this is documented
for both mammalian (primates, rats, mice) and non-mammalian
(chick, zebraﬁsh) developmental models (Goodlett et al., 1989;
Gilliam and Kotch, 1996; Boehm et al., 1997; Chen et al., 2000;
Debelak and Smith, 2000; Su et al., 2001; Loucks andCarvan, 2004;
Downing et al., 2009, 2012a,b; Swartz et al., 2014). Because much
of this work is summarized in other contributions to this volume,
we will not further detail those ﬁndings here. Apart from allelisms
that modulate alcohol clearance rates, the identities of genes that
modify fetal vulnerability to FASD are not well characterized.
ETHANOL INFLUENCES CRANIOFACIAL OUTCOMES IN FASD
Insights into how genetic factors may modify vulnerability to PAE
are informed by an understanding of ethanol’s mechanisms of
action. Unlike other teratogens, ethanol does not have a sin-
gle receptor but instead affects cellular activity though structural
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interactions with diverse proteins that include ligand-gated ion
channels, G-protein-coupled receptors, and intracellular signaling
proteins (Howard et al., 2011). This diversity of targets enables
ethanol to alter multiple signaling pathways and processes that
are essential for normal development. Ethanol’s disruption of
these pathways dysregulates cellular events that are central to
morphogenesis, such as proliferative expansion, migration, dif-
ferentiation, and survival. One well-characterized target of PAE is
the developing face. PAE can cause facial characteristics that have
diagnostic utility and these include a ﬂattened midface, microg-
nathia, smooth philtrum, thin upper lip, and short palpebral
ﬁssures (Klingenberg et al., 2010). During development, the facial
cartilage and bone are derived from the cranial neural crest, a stem
cell population that originates at the neuroectoderm–ectoderm
boundary during the process of neurulation (Sauka-Spengler and
Bronner-Fraser, 2008). Shortly thereafter, cranial neural crest pro-
genitors transform from an epithelial to mesenchymal phenotype,
delaminate, and migrate laterally and ventrally to form the facial
primordia (frontonasal, maxilla, and mandible), branchial arches
(connective tissue of the thymus, thyroid, and cardiac outﬂow
tract), cranial nerve elements, and melanocytes. At the same time,
medial–lateral expansion of the underlying forebrain, or prosen-
cephalon, further deﬁnes the size and relative positioning of the
facial elements (frontonasal, maxilla, mandible, and hyoid). In
humans, these events begin at day 17–18 post-fertilization, before
the pregnancy is typically recognized. Animal models reveal that
ethanol adversely affects many events of craniofacial development
including neural crest induction, survival, migration, and expan-
sion, as well as cranial midline development (Hassler and Moran,
1986; Cartwright et al., 1998; Dunty et al., 2001; Ahlgren et al.,
2002; Rovasio and Battiato, 2002; Yan et al., 2010; Oyedele and
Kramer, 2013). The mechanisms by which ethanol alters these
events are the focus of a recent review (Smith et al., 2014), and
the reader is referred to that article for a detailed discussion of
those ﬁndings. This review instead emphasizes current knowl-
edge of genetic inﬂuences upon craniofacial outcomes in PAE. It
should be noted that women who abuse alcohol typically do so
throughout pregnancy. Thus, it is likely that multiple mechanisms
contribute to the craniofacial dysmorphology that partly typiﬁes
FASD.
GENETIC BACKGROUND INFLUENCES CRANIOFACIAL
OUTCOME IN FASD
Evidence that genome-level differences can inﬂuence cranio-
facial outcomes in PAE emerges largely from animal models.
Mouse strains are especially powerful tools for this work, and
numerous ethanol-sensitive and relatively resistant strains have
been characterized. With respect to cranial development, the
inbred strain C57BL/6J is considered ethanol sensitive, whereas
DBA/J is considered ethanol resistant. Quantitative trait locus
(QTL) mapping of the BxD recombinant lines derived from
these strains established that vulnerability to ethanol’s terato-
genicity has strong heritability and identiﬁed several large QTLs
that may be contributory (Downing et al., 2012a). The related
inbred strains C57BL/6J and C57BL/6N also generate different
facial dysmorphologies in response to PAE, although some of this
may be due to differences in alcohol consumption (Anthony et al.,
2010), as also found for the “U” and “N” rat strains (Wentzel
and Eriksson, 2008). Non-mammalian embryos complement this
rodent work because maternal inﬂuences are removed and direct
embryonic effects can be investigated. The zebraﬁsh strains AB,
Ekkwill, and Tuebingen differ in their levels of cranial cell death,
craniofacial dysmorphology, and overall survival in response to
equivalent ethanol challenge (Loucks and Carvan, 2004). Com-
mercial chick strains show similar variability, wherein broiler
strains had greater cranial reductions compared with layer strains
(Bupp Becker and Shibley, 1998), and layer strains themselves
have differing facial apoptosis patterns and dysmorphologies in
response to equivalent ethanol exposure (Debelak and Smith,
2000; Su et al., 2001). As detailed below, these genetic models
have informed themechanisms bywhich PAEdisrupts craniofacial
development.
GENETIC INFLUENCES UPON HOLOPROSENCEPHALY IN
FASD
The physical size and relationship of craniofacial structures are
inﬂuenced by the underlying prosencephalon or forebrain. During
gastrulation, anterior extension of the prechordal mesendoderm
induces the overlying ectoderm to form neuroepithelium (Sauka-
Spengler and Bronner-Fraser, 2008). Neural crest is speciﬁed
at this ectoderm/neuroectoderm boundary. Simultaneous with
this, the prechordal mesoderm induces sonic hedgehog (shh)
within the neuroepithelial midline. Subsequently, shh activity
at the prosencephalon midline drives expansion not only of the
forebrain but also the overlying facial primordial. Thus, cranio-
facial development is intimately linked with brain induction and
expansion.
Ethanol exposure at gastrulation disrupts midline formation
and thereby craniofacial development. Ethanol exposure at gas-
trulation activates the shh suppressor protein kinase A and the
increased protein kinase A activity downregulates shh at the
embryo’s midline (Aoto et al., 2008). Ethanol-induced apopto-
sis within the anterior prechordal plate, as well as its reduced
expansion, further limits neuroepithelial size and the neural crest
induction ﬁeld (Blader and Strahle, 1998; Aoto et al., 2008).
Consequently, the prosencephalon expansion is reduced and the
overlying facial primordia are malpositioned. Additionally, as
shown in zebraﬁsh, PAE also reduces cholesterol ester pools and
thereby limits substrate availability for the covalent modiﬁcation
of the nascent N-terminal shh protein, which is necessary for the
protein’s membrane association and shh signaling (Li et al., 2007).
The reduced shh expression along the prosencephalon midline
persists developmentally, as do reductions in additional inductive
signals including goosecoid, Foxa2, and Fgf8 (Li et al., 2007; Aoto
et al., 2008; Hong and Krauss, 2012). Work in mice reveals that
targeted ethanol exposure during these gastrulation-stage events
generates the “classic” FAS face, including elongated upper lip,
ﬂattened philtrum, and reduced midface. These changes repre-
sent holoprosencephaly (Sulik, 1984; Lipinski et al., 2012) and are
recreated in both mammalian and non-mammalian models of
FASD (Sulik, 1984; Su et al., 2001; Carvan et al., 2004; Li et al.,
2007; Aoto et al., 2008; Hong and Krauss, 2012; Lipinski et al.,
2012). PAE at mouse e8.5 instead produces a distinct facial out-
come that lacks these holoprosencephalic features, suggesting that
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criteria for recognizing facial dysmorphology in FASD may need
expansion.
Genetic-level alterations within the shh signaling pathway
increase vulnerability to facial dysmorphology in PAE. Mice that
are haploinsufﬁcient in Shh, Gli2, or Cdon generally have normal
crania due to compensation from the remaining allele. However,
ethanol exposure of these same heterozygotes at gestational day
7.0 (e7) causes holoprosencephaly, demonstrating this pathway’s
mechanistic role in producing FASD facial changes (Hong and
Krauss, 2012; Kietzman et al., 2014). It also suggests that hap-
loinsufﬁciency in this pathway increases risk for ethanol-induced
holoprosencephaly. In humans, holoprosencephaly is estimated to
affect 1/16,000 live births and 1/250 conceptuses (Dubourg et al.,
2007); thus, heterozygous carriers at risk for ethanol-induced
damage may be more common in the general population than
appreciated. It is possible that even mild ethanol exposure during
this critical period increases the frequency and severity of human
holoprosencephalic disorders.
GENETIC INFLUENCES UPON NEURAL CREST APOPTOSIS IN
FASD
Ethanol also alters craniofacial development through its induc-
tion of signiﬁcant cell death within neural crest populations. This
occurs at clinically relevant ethanol exposures from 20 to 100 mM
(∼0.1 to ∼0.4 mg%). It has been documented for mouse, chick,
and zebraﬁsh models of PAE (Sulik et al., 1981; Cartwright et al.,
1998; Carvan et al., 2004), suggesting that neural crest sensitivity is
conserved across vertebrates and most likely also occurs in human
exposure. This cell death is apoptotic, as the cells are positive
for extracellular Annexin-V or terminal deoxynucleotidyl trans-
ferase (TUNEL), and their death is prevented by pretreating the
cells with caspase inhibitors (Cartwright et al., 1998; Dunty et al.,
2001; Carvan et al., 2004; Reimers et al., 2006). The apoptosis sig-
niﬁcantly reduces cranial neural crest numbers and contributes
to craniofacial deﬁcits (Sulik et al., 1981; Cartwright and Smith,
1995; Carvan et al., 2004; Garic et al., 2011; Flentke et al., 2014b).
Multiple mechanisms contribute to this apoptosis, including the
production of reactive oxygen species (Chen et al., 2013), genera-
tion of intracellular calcium transients (Debelak-Kragtorp et al.,
2003), and the loss of tropic support from β-catenin (Flentke
et al., 2011) and/or from sonic hedgehog (Ahlgren et al., 2002). The
details of these mechanisms have been recently reviewed (Smith
et al., 2014).
Genetic models offer insights into the mechanisms mediat-
ing this apoptosis. For example, neural crest populations from
the mouse strain C56BL/6J have much greater apoptosis than do
ICR neural crest at equivalent ethanol exposures (50–200 mM;
Chen et al., 2000). The membrane content of GM1 ganglioside
is enriched in ICR cells compared with those from C57BL/6J,
and addition of GM1 ganglioside attenuates ethanol’s damage,
suggesting that differences in GM1 content may affect ethanol
vulnerability. Screens of zebraﬁsh mutants have identiﬁed multi-
ple genes that inﬂuence craniofacial outcomes in ethanol exposure
including pdgfra, plk1, hinfp, mars, vangl2, and foxi1 (McCarthy
et al., 2013; Swartz et al., 2014). These are all thought to be
loss-of-function mutations and all worsened the craniofacial dys-
morphology in response to ethanol. At least two of these, pdgfra
and plk1 loss-of-function, also enhance apoptosis within ethanol-
treated cranial regions. Importantly, PDGFRA also could be linked
to craniofacial defects in individuals with FASD (McCarthy et al.,
2013). It should be noted that loss-of-function of additional
craniofacial genes did not modify the risk for ethanol-induced
facial defects in this model, including cyp26b1, gata3, smad5,
smoothened, mitfa, and neurog1, among others. This endorses that
ethanol’s mechanism is speciﬁc rather than generalized.
NEURAL CREST APOPTOSIS – INSIGHTS FROM THE CHICK
MODEL
The developing chick embryo is advantageous for neural crest
investigations due to its ready accessibility and ease of exper-
imental manipulation. Much of the mechanism that governs
neural crest apoptosis within this ethanol exposure model is
now understood and this pathway is shown in Figure 1. In
these cells, ethanol interacts with a G-protein-coupled receptor
of yet-unknown identity and having a binding pocket that accom-
modates aliphatic alcohols from C1 through C5 (Garic-Stankovic
et al., 2005, 2006). Alcohol binding stimulates G-protein signaling
in which a pertussis toxin-sensitive Gβγ dimer activates phos-
pholipase Cβ, likely the β4 isozyme that is expressed in neural
crest (Garic-Stankovic et al., 2005). Within seconds of ethanol
exposure, the resulting production of phosphoinositides initiates
calcium mobilization from intracellular stores and the capacitative
entry of extracellular calcium (Figures 2A,B; Debelak-Kragtorp
FIGURE 1 | Diagram of the calcium/β-catenin pathway by which
ethanol causes the apoptosis of cranial neural crest populations, as
deciphered for chick embryos having 1–10 somites; additional details
in text. Ethanol’s interaction with a G-protein-coupled receptor of unknown
identity activates a calcium transient that originates from Gβγ, PLCβ, and
phosphoinosityl phosphate release. The calcium transient stimulates
calmodulin and CaMKII. CaMKII phosphorylates and thereby destabilizes
β-catenin, abrogating the latter’s transcriptional activity. This removes
trophic support from neural crest including genes critical for neural crest
development (snai2, FoxD3,Wnt6 ). Accompanying reductions in bcl2 and
ribosomal proteins may also be contributory.
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FIGURE 2 | Key events in ethanol-induced apoptosis of chick cranial
neural crest. (A) Diagram of chick embryo having 3 somites (stage 8-). (B)
Exposure to 52 mM ethanol instigates the mobilization of intracellular calcium
stores (*) within the early headfold (boxed region) as quantiﬁed using Fura2.
Shown is dorsal view with anterior to the top. (C)The calcium transient
selectively activates CaMKII within the anterior neural folds including neural
crest (arrows) as detected using antibody directed against phospho-CaMKII
(green signal, arrows). A dorsal view of the headfolds is depicted, anterior to
the top. (D) Among other targets, CaMKII phosphorylates and destabilizes
β-catenin protein (green signal at green arrows in boxed region) within the
dorsal neural folds enriched in neural crest. Shown is a transverse section,
dorsal at top, through the headfold of embryos having three somites; blue
indicates DAPI-stained nuclei. (E) Subsequently, there is signiﬁcant apoptosis
(red signal) within ethanol-exposed dorsal neuroprogenitors of the hindbrain
including neural crest (strong green signal), detected using antibody against
the neural crest marker snail2. The saline-treated control hindbrain displays
little cell death. Shown is a transverse section through rhombomere 4, which
normally lacks appreciable cell death, of embryos having 16–18 somites;
dorsal roof is at the top. Chick embryos normally have a low-level green
autoﬂuorescent background.
et al., 2003; Garic-Stankovic et al., 2005). This calcium transient
stimulates calmodulin and, within 1 min of ethanol exposure,
the calmodulin-dependent kinase CaMKII is activated within
neural crest and neuroprogenitors within the dorsal headfolds
(Figure 2C, Garic et al., 2011). This action of ethanol is spe-
ciﬁc to these cells and CaMKII is not activated in ventral neural
populations or in the presomitic mesoderm. CaMKII activation
converts the short-lived calcium transient into a longer lived effec-
tor of neuroprogenitor fate, as CaMKII phosphorylates a number
of downstream proteins within the cell. The induction of an intra-
cellular calcium transient and CaMKII activity is essential and
sufﬁcient to produce neural crest apoptosis (Figure 2E).
Trophic support for early neural crest progenitors is pro-
vided by canonical Wnt signaling and its transcriptional effector
β-catenin, which interacts with TCF/LEF proteins to induce gene
expression (Kohn and Moon, 2005; MacDonald et al., 2009). Tran-
scriptionally active β-catenin is indispensible for neural crest
survival (Brault et al., 2001). Its transcriptional activity is nega-
tively regulated through phosphorylation, which targets β-catenin
for ubiquitination and proteolytic degradation. Ethanol’s calcium
transient destabilizes nuclear β-catenin within 2 h of ethanol
addition (Figure 2D) and signiﬁcantly reduces its transcriptional
activity, as measured using TopFlash reporter constructs and
quantitation of known Wnt target genes (Flentke et al., 2011).
β-Catenin over-expression in ethanol-treated neural crest is sufﬁ-
cient to rescue their survival and prevent their apoptosis (Flentke
et al., 2011), and agents that sequester calcium similarly stabilize
β-catenin in ethanol’s presence. Calcium is known to destabilize
transcriptional β-catenin through multiple mechanisms including
direct phosphorylation by protein kinase C, cleavage by calpain
proteases, and indirectly through CaMKII phosphorylation of
TCF/LEF. The GSK3β and JNK kinases can also directly phospho-
rylate and destabilize β-catenin (Kohn and Moon, 2005). Of those
known effectors, only CaMKII inhibition stabilizes β-catenin and
its transcriptional activity in ethanol-treated neural crest (Flen-
tke et al., 2014a). Inhibiting other β-catenin effectors does not
affect the protein’s stability or cell survival in ethanol-treated cells.
Moreover, CaMKII directly phosphorylates β-catenin at three evo-
lutionarily conserved andpreviously uncharacterized sites at T332,
T472, and S552. Thus, β-catenin is a novel target for CaMKII’s
kinase activity. Blocking any of the above steps within ethanol-
exposed cells, using small molecules or targeted misexpression of
loss/gain-of-function mutants within this pathway, fully prevents
the apoptosis triggered by ethanol exposure (Debelak-Kragtorp
et al., 2003; Garic-Stankovic et al., 2005; Flentke et al., 2011, 2014a;
Garic et al., 2011).
Chick neural crest is not the only embryonic cell population
in which an ethanol-induced calcium transient initiates apop-
tosis. Key elements of this pathway (calcium release, CaMKII
activation Figure 2E) also mediate ethanol-induced apoptosis
within zebraﬁsh neural crest progenitors from equivalent devel-
opmental stages (Flentke et al., 2014b). Ethanol similarly invokes
a pro-apoptotic, intracellular calcium transient within the gastru-
lating mouse, as well as in human cytotrophoblast cells and in
mouse cerebellar neurons (Kilburn et al., 2006; Kouzoukas et al.,
2013; Bolnick et al., 2014). Thus, this pro-apoptotic mechanism
of ethanol’s action appears to be evolutionarily conserved and
occurs in diverse cell lineages, at least within the embryo and fetus.
Ethanol also invokes this same phosphoinositide-stimulated cal-
cium transient in the mouse morula/blastocyst; however, it does
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not cause apoptosis and instead stimulates pathways that gov-
ern implantation and proliferative expansion (Winston and Maro,
1995). This suggests that how cells interpret ethanol’s calcium
transient is lineage dependent.
GENOMIC FACTORS MODIFY CALCIUM-MEDIATED NEURAL
CREST APOPTOSIS
The serendipitous discovery of ethanol-sensitive and -resistant
chicken strains providednovel insights into themechanismsof this
ethanol-mediated apoptosis. Layer ﬂocks in the authors’ poultry
facility are replaced annually and one such exchange revealed that
the birds’ genetic background affects neural crest vulnerability to
ethanol-induced apoptosis. As with inbred mice, commercial layer
strains reproducibly fall along a continuum of ethanol responses.
Some strains, such as Hy-Line W98 and W36, display high levels
of neural crest apoptosis and a pronounced craniofacial dysmor-
phology, whereas other strains have little cell death and a relatively
normal face (Debelak and Smith, 2000; Su et al., 2001). Vulner-
ability to ethanol-induced cardiac defects is similarly shaped by
genetics (Cavieres and Smith, 2000). The ethanol content of eggs
and embryos is equivalent and cannot account for this differential
vulnerability. Because commercial chick strains are derived from
hybrid crosses of sib-grandparent stocks, it is impractical to iden-
tify potential loci using traditional genetic breeding approaches.
We therefore turned to deepDNA/RNA sequencing to characterize
the transcriptomes of ethanol-sensitive and -resistant strains. The
Gallus gallus genome was among the ﬁrst to be sequenced and it is
sufﬁciently annotated for detailed genetic analysis.
This comparison was accomplished using a unique genetic
resource, two related chicken lines of the Hy-Line W98 strain
that were selected for multiple traits affecting egg production.
These lines were maintained as distinct closed ﬂocks for perhaps
as many as 40 generations. Line W98S (so designated because it
originated from Hy-Line’s Spencer, IA, facility) displays a robust
calcium transient and high apoptosis in response to ethanol chal-
lenge (Figure 3; Garic et al., 2014), and it was utilized in many
of the authors’ ethanol publications in the decade following 2000.
In contrast, the related W98 line W98D (originating from Hy-
Line’s Dallas Center, IA, facility) has ethanol-invoked calcium
transients that are 30–40% lower than those of W98S at exposure
FIGURE 3 | Chick lines of the W98 background differ in their sensitivity
to ethanol-induced apoptosis. (A) There is appreciably more
ethanol-induced cell death (white dots) in neural crest and neuroprogenitors
in line W98S as compared with ethanol-treated W98D. Cell death levels in
the latter do not differ from that in saline-treated controls. Here, cell death
is visualized using acridine orange, which detects apoptosis in this model;
dorsal view is shown. (B) W98S embryos (•) mobilize greater intracellular
calcium concentrations (quantiﬁed using Fura2) in response to ethanol
challenge than do W98D embryos (◦) at equivalent ethanol exposures. Their
calcium release is dose-dependent. (C) W98S (•) has signiﬁcantly more
apoptotic cells than does W98D (◦) in response to equivalent ethanol
exposures. Values are mean ± SD for 3–8 embryos/treatment; *p < 0.001
vs. 0 mM ethanol for within-strain comparison; †p < 0.001 between
W98S/W98D at equivalent ethanol dose.
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to equivalent ethanol concentrations. Both strains achieve differ-
ent plateau values, indicating that their differential response is not
due to a shifted dose–response curve. Non-linear regression of
these dose-response curves ﬁnds that their ethanol-induced cal-
cium responses share similarKds (51mMvs. 55mM)anddifferent
maxima (Figure 3B; Garic et al., 2014). This suggests that their
neural crest progenitors possess ethanol-binding sites with sim-
ilar afﬁnities and that they differ in transduction of the ethanol
signal.
High-throughput transcriptome sequencing (RNA-Seq) of
neural crest-enriched headfolds from W98S and W98D identi-
ﬁed genomic difference that might inﬂuence ethanol sensitivity.
Cells were not exposed to ethanol, so as to identify baseline dif-
ferences that might potentially shape calcium and/or β-catenin
signaling. The analysis identiﬁed 363 genes that are differen-
tially expressed between W98S and W98D (Garic et al., 2014). Of
these, 171 genes (47.1%) are increased in W98S and 192 genes
(52.9%) are signiﬁcantly decreased. Additionally, 18 genes within
the Wnt/β-catenin signaling pathway have signiﬁcantly differen-
tial expression. Importantly, the ethanol-sensitive W98S cells have
signiﬁcantly reduced expression of β-catenin itself (0.916-fold vs.
W98D, p = 0.00588), as well as the two calmodulin isoforms
that detect the calcium transient in these cells (CALM, 0.898-
fold, p = 0.0170; CALM2, 0.836-fold, p = 0.060). W98S also
has increased expression of two distinct Wnt/β-catenin antago-
nists, SHISA2 (1.106-fold, p = 2.34 × 10−7) and the secreted
frizzled receptor protein SFRP2 (1.193-fold, p = 7.08 × 10−8),
which is normally enriched in hindbrain neural crest progenitors
fated for apoptosis (Ellies et al., 2002). Although these different
expression levels represent transcripts and not protein, it sug-
gests that cells derived from these two lines have foundational
differences in how they perform Wnt/β-catenin-dependent sig-
naling (Figure 4, left). In ethanol-sensitive W98S, the reduced
β-catenin expression coupled with elevations in two canonical
Wnt antagonists could dampen β-catenin’s transcriptional activ-
ity within its neural crest as compared with W98D. Similarly,
their lower content of both calmodulin isoforms could alter
their respective calcium signaling dynamics. Taken together, these
changes could shift the ethanol dose–response curve such that
W98D cells are buffered against β-catenin transcriptional losses,
whereas W98S is more vulnerable to those losses. One caveat
to this analysis is that these headfolds are composed of neu-
ral crest and neuroprogenitors and thus not all these genes are
present in neural crest. However, Wnt signaling genes such as
β-catenin and SFRP2 are restricted to neural crest at these stages
and their identiﬁcation in this model likely informs their cellular
responses.
Additional analysis of this gene set using the Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) revealed 10 biologically
characterized pathways with signiﬁcantly differential representa-
tion between the two lines (Table 1; Garic et al., 2014). These
pathways, in turn, largely contribute to two major cellular net-
works. In the ﬁrst, four of these pathways mediate the ﬂow of
cellular information from nucleus to cytosol and included the
spliceosome (p = 7.02 × 10−8), RNA transport (p = 0.00676),
ribosome (p = 1.85 × 10−47), and protein processing in the
endoplasmic reticulum (p = 0.00109) gene clusters. The second
FIGURE 4 | Integration of genetic findings with known
ethanol-induced signals in neural crest.The left panel shows how the
expressions of genes that participate in ethanol’s apoptosis are altered in
within ethanol-sensitiveW98S as compared against ethanol-resistant
W98D. Fold-changes in expression are presented. The right panel proposes
a mechanism by which ribosome dysgenesis could interact with MDM2 to
stimulate p53-mediated apoptosis. In response to cellular stress such as
ethanol, a decrease in ribosome synthesis leads to ribosome proteins
interacting with MDM2. MDM2 no longer silences p53 and permits
p53-mediated activities, including apoptosis, to increase within cells.
Table 1 | KEGG pathway enrichments inW98S vs.W98D.
KEGG Identity No. of
genes
Significance
3010 Ribosomal 38 1.85 × 10−47
190 Oxidative phosphorylation 18 1.10 × 10−11
4260 Cardiac muscle 10 5.71 × 10−9
3040 Spliceosome 13 7.02 × 10−8
4141 Protein processing in ER 9 0.00109
4530 Epithelial tight junctions 6 0.00309
4114 Oocyte meiosis 6 0.00585
3013 RNA transport 7 0.00676
1100 Metabolism 25 0.00983
4110 Cell cycle 6 0.0140
10 Glycolysis/gluconeogenesis 18 0.0530
4145 Phagosome 5 0.0600
Data from Garic et al. (2014).
differentially represented network includes two pathways that
govern energy generation and include metabolism (p = 0.00983)
and oxidative phosphorylation (p = 1.10 × 10−11), and near
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signiﬁcance for glycolysis/gluconeogenesis (p = 0.0530). Also dif-
ferentially represented are KEGG pathways involving the cell cycle
(p = 0.0140) and epithelial tight junctions (p = 0.00309).
NEURAL CREST AND RIBOSOME BIOGENESIS
The most compelling ﬁnding from the RNA-Seq comparison of
ethanol-vulnerable/resistant neuroprogenitors is the signiﬁcant
differential enrichment of 38 genes that encode ribosome pro-
teins. This includes 27 large and 11 small ribosomal subunit
proteins (Figure 5), as well as two additional genes that par-
ticipate in ribosome biogenesis, pescadillo (PES-1, 1.198-fold,
p = 0.0145) and NSA2 (1.340-fold, p = 3.81 × 10−6). Of
these ribosomal proteins, 25 were decreased and 13 increased in
ethanol-sensitiveW98S. Remarkably, ribosomal gene clusters were
also signiﬁcantly altered in two independent studies of ethanol
exposure to mouse neural folds of comparable developmental
stages to our chick embryos (Green et al., 2007; Downing
et al., 2012b; see this volume). Ribosomal gene clusters addi-
tionally emerged from independent studies of ethanol-treated
neuronal cultures (Rahman and Miles, 2001; Gutala et al.,
2004). Perhaps, further supporting its importance, haploin-
sufﬁciency in the methionyl tRNA synthetase (mars), which
donates the ﬁrst amino acid to initiate protein translation,
also heightens embryo sensitivity to ethanol-induced cran-
iofacial deﬁcits (Swartz et al., 2014). The repeated emer-
gence of ribosomal protein clusters from multiple compar-
isons of ethanol-treated neuroprogenitors suggests that riboso-
mal activity may be an integral component of cellular ethanol
responses.
Why are ribosomal proteins potentially relevant for
neural crest apoptosis? Ribosome synthesis is complex
(Granneman and Baserga, 2004). Ribosomes convert messenger
FIGURE 5 | Network interactions from the Database for Annotation,Visualization, and Integrated Discovery (DAVID) depict the relationships between
the 38 ribosomal proteins that have significantly different expression between ethanol-sensitiveW98S and ethanol-resistantW98D neural folds.
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RNA (mRNA) information into protein. Composed of four ribo-
somal RNAs (rRNA) and approximately 80 proteins, ribosomes
bind mRNA, provide docking sites for codon recognition by
amino acyl-transfer RNA, and catalyze the synthesis of nascent
protein. The cell nucleolus denotes locations of polycistronic
rRNA synthesis, processing, and ribosome assembly. The rRNA
emerges as a single transcript that is then modiﬁed by small
nucleolar RNAs (snoRNAs) and protein cofactors that medi-
ate cleavage, methylation, and pseudouridylation of the rRNA.
Ribosome biogenesis imposes a signiﬁcant energy demand and,
for rapidly proliferating cells, occupies as much as 80% of the
energy budget because cells must disassemble the nucleolus and
replenish their ribosomes with each mitotic division (Schmidt,
1999).
Given its high use of cellular resources, ribosome biogenesis
has been recently recognized as an important sensor of cellular
stress through its regulation of p53 activity (Figure 4, right; Kruse
and Gu, 2009; Fumagalli and Thomas, 2011). The tumor sup-
pressor protein p53 accumulates in response to stress to effect cell
cycle arrest, apoptosis, DNA repair, and other processes. Interac-
tions with the E3 ubiquitin ligase MDM2 silence p53 through
MDM2-catalyzed ubiquitination and proteosomal destruction.
When ribosome biogenesis is perturbed, as through reduced ATP
availability or imbalanced ribosome protein content, ribosomal
proteins such as RPL5, RPL11, RPL23, and RPS7 instead inter-
act with MDM2 to suppress its ubiquitinase activity and thereby
stabilize p53 and stimulate p53-mediated activities including cell
cycle arrest and apoptosis.
Defects in ribosome biogenesis are clinically signiﬁcant.
Human ribosomopathies are not embryolethal and are associ-
ated with anemia, short stature, limb and heart defects, and,
of relevance to this discussion, can feature signiﬁcant cranio-
facial deﬁcits including a ﬂattened nasal bridge, micrognathia,
epicanthal folds, cleft lip/palate, and altered palpebral ﬁssues
(Narla and Ebert, 2010; Fumagalli and Thomas, 2011). These
facial changes echo those of FASD and suggest that cranial
neural crest is especially sensitive to ribosome dysbiogenesis.
Animal models conﬁrm that loss-of-function mutations in ribo-
some proteins or effectors of ribosome biogenesis can cause
cell cycle arrest and p53-mediated apoptosis within neural crest
progenitors, the best described of these being Treacher-Collins
syndrome (Trainor, 2010). Five of the differentially expressed
ribosome proteins in W98S/D headfolds are known to regu-
late MDM2/p53 interactions (Table 2; RPL5, RPL11, RPL12,
RPS15, RPL23). Additionally, nine of these ribosomal proteins are
causative in the craniofacial ribosomopathy Diamond–Blackfan
anemia (RPL5, RPL11, RPL26, RPL27, RPL35A, RPL36, RPS10,
RPS15, RPS17). Additional attention to ribosome biogenesis
arises from the analysis of these same cell populations 6 h
following ethanol challenge, wherein the greatest gene cluster
change again involves ribosome biogenesis (p = 2.2 × 10−21;
Garic et al., 2014). Similar to the afore-mentioned reductions
in shh signaling (Ahlgren et al., 2002) or in Pdgfra (McCarthy
et al., 2013), genomic-level alterations in ribosomal proteins
might disturb the balance of MDM2/p53 regulation that, in
of itself, is insufﬁcient to initiate apoptosis, but does so upon
the additional stress of ethanol challenge (Figure 4). Indeed,









RPL5 1.24 4.72 × 10−19 X X
RPL11 0.88 0.00555 X X
RPL12 0.75 4.63 × 10−23 X –
RPL23 0.87 2.56 × 10−6 X –
RPL26 0.89 0.00182 – X
RPL27 0.83 1.27 × 10−21 – X
RPL35A 0.85 5.01 × 10−8 – X
RPL36 0.49 3.69 × 10−34 – X
RPS10 0.93 0.0226 – –
RPS15 1.17 1.67 × 10−5 X X
RPS17 0.765 6.43 × 10−13 – X
Adapted from Narla and Ebert (2010), Fumagalli and Thomas (2011), and Garic
et al. (2014).
interactions between mTOR and ribosome biogenesis control
both cellular anabolism and decisions regarding p53 activity
(reviewed in Shimobayashi and Hall, 2014), and it is tempt-
ing to speculate that these mTOR and ribosome/p53 ﬁndings
have identiﬁed different aspects of the same mechanism. Given
the established role for calcium/β-catenin signals in this model
of ethanol-induced apoptosis, we additionally speculation that
the combination of diminished β-catenin activity and ribo-
some dysbiogenesis may interact to stimulate these cells’ pro-
apoptotic fate. Studies are underway to evaluate this hypothesis
in detail.
ENERGY METABOLISM AND APOPTOSIS
Excessive ethanol suppresses energymetabolism through the com-
petition for cellular reducing equivalents, through inhibition of
lipolysis, and through direct effects upon mitochondrial activity
(Bunout, 1999). Embryos have a high energy demand due to their
obvious anabolic and pro-proliferative state. The avian embryo’s
primary energy source is triglyceride β-oxidation and thus oxida-
tive phosphorylation; unlike mammals, yolk-bearing embryos can
convert acetyl-CoA subunits into glucose via gluconeogenesis.
Ethanol-vulnerable cells fromW98S had signiﬁcant up-regulation
of multiple components of oxidative phosphorylation including
many proteins in complex I/NADH dehydrogenase, cytochrome
c oxidase, and the ATP synthase (Figure 6). However, sev-
eral components of the cytochrome c reductase and cytochrome
c oxidase were signiﬁcantly lower compared with W98D. It is
possible that these changes altered the metabolic ﬂux within
W98S relative to W98D, but unfortunately those embryos are no
longer available to test this hypothesis. These metabolic differ-
ences might also be linked to the ribosomal changes between
these strains, given the high energy cost of ribosome biogen-
esis and its role as a cellular stress sensor. It is likely that
these differences in energy metabolism resulted from commer-
cial pressures during line selection, because efﬁciency in nutrient
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FIGURE 6 | Network interactions from DAVID depict the relationships between the 18 glycolytic and 18 oxidative phosphorylation genes that have
significantly different expression between ethanol-sensitiveW98S and ethanol-resistantW98D neural folds.
utilization and feed conversion are desirable agricultural traits
to improve growth and production. Similarly, the emphasis on
improved growth may have also created efﬁciencies in ribosome
biogenesis. Given the importance of energy generation for the
rapidly growing embryo, relative differences in energy metabolism
may have inﬂuenced cellular vulnerability to ethanol-induced
stress.
SUMMARY
In summary, genetic approaches have informed the multiple
mechanisms by which ethanol disrupts craniofacial morpho-
genesis. The use of haploinsufﬁcient mice has demonstrated
how PAE suppresses shh signaling and generates holoprosen-
cephalic features when exposure occurs during gastrulation.
Zebraﬁsh mutants implicate additional mechanisms through
effects upon mTOR signaling and cell cycle regulation. Tran-
scriptome sequencing of both mouse and avian embryos with
differing ethanol sensitivities has further identiﬁed novel poten-
tial mechanisms including energy metabolism and/or ribosome
biogenesis; in turn, these could be related to each other as
well to contributions from mTOR. That ribosomal dysregu-
lation also emerged from multiple, independent analyses of
ethanol responsive genes in mouse neural folds make ribo-
some biogenesis a strong candidate to modify and contribute to
ethanol’s damage. Our ﬁndings suggest that genetic-level differ-
ences in neural crest vulnerability to PAE may partially explain
why only a percentage of ethanol-exposed pregnancies exhibit a
postnatal craniofacial dysmorphology. Next-generation sequenc-
ing offers a rapid and comparatively affordable approach to
identify additional genomic candidates that modify craniofa-
cial responses to ethanol. Together with advances in epigenetics,
this research will greatly advance our understanding of how
genes and environment interact to shape individual outcomes in
FASD.
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